Endometriosis is a common estrogen-dependent disease characterized by growth of endometrial glands and stroma outside the uterine cavity. Associated with pelvic pain and infertility, endometriosis is estimated to affect up to 10% of women or 176 million women worldwide. Despite its common occurrence and debilitating impact on the lives of affected women, the cause of endometriosis remains ill defined. While retrograde menstruation is the most widely accepted theory of causation, regurgitation of menstrual effluent through the fallopian tubes occurs in approximately 90% of women. Since only a fraction of women develop endometriosis, factors other than access of menstrual effluent to the pelvic cavity alone must contribute to development of endometriosis. Therefore, unique features of menstruated cells destined to become endometriotic lesions; defects in immune surveillance or some combination of the above are thought to contribute to formation of endometriotic lesions. However, critical steps in the pathogenesis of endometriosis have yet to be elucidated.
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Emerging evidence over the last several years has revealed signaling pathways central to the pathophysiology of endometriosis. Dysregulation of aromatase expression leading to de novo production of estrogens [1] together with downregulation of 17β-hydroxysteroid dehydrogenase type-II result in high local tissue estrogen concentrations of endometriotic implants. Furthermore, recent studies revealed that endometriotic implants over express estrogen receptor β (EsR2) [1, 2] leading to transcriptional repression of estrogen receptor α (EsR1) and progesterone receptor expression. Overexpression of EsR2 modulates tumor necrosis factor-α (TNF-α) mediated apoptosis [2] and enhanced recruitment of inflammatory mediators. In animal models, endometriotic implants formed in wild-type mice form larger implants than implants generated with loss of EsR2 function [2] . Taken together, these studies demonstrate that endometrial implant survival, growth, evasion from apoptosis, and immune dysregulation are estrogen-dependent processes driven by dysregulation of local tissue estrogen levels and preferential upregulation of EsR2. However, although the central role of estrogen signaling in established endometrial lesions is clear, it remains uncertain if these are adaptive responses limited to established lesions or key events leading to the development of disease. Several lines of evidence suggest that lesion initiation and progression are pathophysiologically distinct phases. Results of a recent study [3] , using estrogen receptor and interleukin 6 receptor knockout mice and tissue recombination experiments, showed that, unlike established endometriotic implants, newly forming implants are estrogen independent. Rather the initial steps in endometriotic implant development are dependent on immune system modulation. Further evidence supporting the proposal of functionally different phases in endometriotic lesion lifespan is derived from changes in markers of endometriosis. Specifically, higher serum microRNA-451 (miR-451) has recently been demonstrated in women with endometriosis compared to a reference population [4] , an observation replicated in a baboon model of endometriosis [5] . Dysregulation of miR-451 expression was detectable in eutopic endometrium as early as 3 months postinduction of endometriosis in the baboon model [5] . However, also in the baboon model, differences in circulating miR-451 peaked and only achieved significance at 6 months after endometriotic lesion induction [6] . Taken together, these data suggest that established disease is functionally distinct from implant development.
Endometriosis is a benign disease that, unlike cancer, lacks the capacity for metastasis but, similar to cancer, shed endometrial cells survive under hypoxic conditions, attach to distant anatomical sites, undergo epithelial to mesenchymal transition (EMT), and develops an invasive phenotype. A recent study [7] has shown that under hypoxic conditions, endometrial stromal cells upregulate hypoxiainducible factor-1α (HIF-1α) expression, activate the self-digestion pathway (autophagy), and promotes cell migration and invasion; all key steps in the development of endometriosis. Expanding upon their prior findings, Liu and colleagues [8] have shown increased expression of HIF-1α and microtubule light chain protein (LC3), a marker of autophagy, in ectopic endometrial lesions compared to eutopic endometrium of women with and without endometriosis.
To evaluate the effect of hypoxia on endometrial cell function, tissue culture studies were used. Cultures of Ishikawa cells (an endometrial epithelial cancer cell line) or primary epithelial cells, obtained from endometrial biopsies of women with endometriosis, revealed that EMT is regulated by hypoxia-induced autophagy [8] . Furthermore, hypoxia also promoted endometrial epithelial cell invasion in culture. This report expands the literature illustrating that early events important in the establishment of endometriotic lesions are triggered by cell response to hypoxic conditions leading to activation of the autophagy cascade, which in turn drives EMT, and enhanced invasion of endometriotic cells. However, it is unclear if these results will readily translate to eutopic epithelial cells from healthy cycling women who do not have endometriosis. Furthermore, it is uncertain that these findings will relate to all types of endometriosis such as deep infiltrating endometriosis which is thought to have a different origin than peritoneal or endometriomas and to be a specific disease [9] . Future studies will also be needed to clarify the impact of interaction between cells in the implantation site and endometrial cells since different types of endometrial implants are thought to be functionally distinct [10] .
While endometriosis remains a complex disease of unknown cause, results of recent animal and tissue culture studies are providing a clearer picture of the pathophysiology. Initiation of endometriotic lesions is likely an estrogen-independent process and the new findings from Li and colleagues [8] suggest that hypoxia-induced activation of the autophagy cascade is central to EMT and the invasive phenotype characteristic of cells of endometriotic implants. Future studies will be necessary to define the mechanisms underlying dysregulation of hypoxia-induced autophagy, EMT, and invasion characteristics of endometrial cells from women with endometriosis. Following lesion initiation, estrogen dependence emerges as a central mediator of lesion survival, growth, and immune modulation in established lesions. The mechanisms leading to dysregulation of EsR2 expression is another endometriosis research priority that remains to be addressed.
